Differential expression of lymphoid and myeloid markers on differentiating hematopoietic stem cells in normal and tumor-bearing adult human liver
Open Access
- 1 June 2000
- journal article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 31 (6) , 1251-1256
Abstract
The presence and phenotype of lineage-committed hematopoietic progenitors in the normal adult human liver (AHL) were investigated and compared with the profiles of differentiating hematopoietic precursor populations detected in liver bearing metastases of colonic origin. Levels of hematopoietic stem cells (HSCs) (CD34+CD45+) detected in hepatic mononuclear cell (HMNC) populations were increased 6-fold when compared with matched peripheral blood samples. In normal liver, less than 5% of HSCs expressed the myeloid-associated antigen, CD33, whereas considerable proportions expressed lymphoid-associated markers (T cell, 33.39%; B cell, 17.39%; and natural killer [NK] cell, 37.17%). Significant increases were observed in the relative proportions of hepatic HSCs coexpressing CD33 (20.53%; P = .001), and the T-cell marker (CD7, 58.13%; P = .02) in tumor-bearing liver compared with normal liver. HSCs with B-cell progenitor phenotype (CD19+) were significantly decreased in tumor-bearing liver (0.06%; P = .02). Despite these differences, the activation status of hematopoiesis, as measured by the coexpression of the differentiation and activation markers, CD38 and CD45RA, did not differ significantly between normal and tumor-bearing liver. These results indicate that the normal AHL harbors lineage-committed hematopoietic progenitors, and the vast majority of these progenitors express lymphoid-associated antigens with changes occurring in both the myeloid and lymphoid compartments of the hepatic hematopoietic pathway on tumor challenge. While tumor-bearing livers are enriched for intrahepatic myeloid precursors and T-cell progenitor cells, further studies are required to establish the origin and in situ development potential of hepatic HSCs in the adult human and their role in tumor immunity.Keywords
Funding Information
- Health and Research Board of Ireland
- Dublin Institute of Technology
- St. Vincent's Hospital Liver Trust
This publication has 21 references indexed in Scilit:
- Monocyte-mediated Tumoricidal Activity via the Tumor Necrosis Factor–related Cytokine, TRAILJournal of Experimental Medicine, 1999
- Differentiation of Forbidden T Cell Clones and Granulocytes in the Parenchymal Space of the Liver in Mice Treated with EstrogenCellular Immunology, 1998
- Requirement for V α 14 NKT Cells in IL-12-Mediated Rejection of TumorsScience, 1997
- RAG1, RAG2 and pre‐T cell receptor α chain expression by adult human hepatic T cells: evidence for extrathymic T cell maturationEuropean Journal of Immunology, 1996
- Cytotoxic activity against tumour cells mediated by intermediate TCR cells in the liver and spleenImmunology, 1996
- Expression of CD34 in endothelial cells, hematopoietic progenitors and nervous cells in fetal and adult mouse tissuesEuropean Journal of Immunology, 1995
- Extramedullary erythropoiesis in human liver graftsHepatology, 1995
- Isolation and purification of large quantities of fresh human Kupffer cells, which are cytotoxic against colon carcinomaHepatology, 1995
- Increase in the proportion of granulated CD56+ T cells in patients with malignancyClinical and Experimental Immunology, 1994
- Expression of Thy-1 on human hematopoietic progenitor cells.Journal of Experimental Medicine, 1993